Follow The Filings

IMVT position history

The shares of Immunovant (IMVT) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q3: 22,500 shares, $864K, 0.27% of portfolio, New
  2. 2023 Q4: 40,742 shares, $1.7M, 0.41% of portfolio, Add +81.1%
  3. 2024 Q1: 29,416 shares, $950K, 0.22% of portfolio, Reduce −27.8%
  4. 2024 Q2: 47,916 shares, $1.3M, 0.30% of portfolio, Add +62.9%
  5. 2024 Q3: 51,996 shares, $1.5M, 0.35% of portfolio, Add +8.5%
  6. 2024 Q4: 107,996 shares, $2.7M, 0.68% of portfolio, Add +107.7%
  7. 2025 Q1: 169,996 shares, $2.9M, 0.82% of portfolio, Add +57.4%
  8. 2025 Q2: 191,493 shares, $3.1M, 0.85% of portfolio, Add +12.6%
  9. 2025 Q3: 191,493 shares, $3.1M, 0.76% of portfolio
  10. 2025 Q4: 150,524 shares, $3.8M, 0.89% of portfolio, Reduce −21.4%
  11. 2026 Q1: 150,524 shares, $3.7M, 0.85% of portfolio
  12. 2026 Q2: 149,524 shares, $5.8M, 1.1% of portfolio, Reduce −0.7%
  13. 2026 Q3: 135,524 shares, $4.6M, 0.98% of portfolio, Reduce −9.4%
Holdings date Value % of holdings Shares Filing date All 13F holders